In this guide
What is Krill Oil?
Krill-oil grams, phospholipid grams and EPA plus DHA grams are different label quantities. Comparative trials are small and do not prove clinical superiority. Krill supplies EPA and DHA, but U.S. adult AIs apply to ALA only. No EPA/DHA or krill-oil DRI is established. [1]
Typical Krill Oil Protocols
| Source and population | Form and amount each time | Frequency | Total exposure | Duration or boundary |
|---|---|---|---|---|
| Ulven 2011 · 113 adults with normal/slightly high lipids | Krill oil 3 g/day, supplying 543 mg EPA+DHA/day | Six capsules daily; distribution not recovered | 543 mg EPA+DHA/day | 7 weeks; biomarker comparison |
| Deinema 2017 · 60 adults with dry eye | Krill oil supplying 945 mg EPA + 510 mg DHA/day | Daily; administration count not recovered from abstract | 1,455 mg EPA+DHA/day | 90 days |
| Urina-Triana 2026 · 47 adults with mild/moderate hypertriglyceridemia | Phospholipid-bound omega-3 supplying 825 mg EPA+DHA/day | Daily total; count not recovered from the article excerpt | 825 mg EPA+DHA/day | 12 weeks; 44 completed |
These rows reproduce sources. Do not average them into one universal regimen.
From source to outcome
Not krill-oil grams.
No clear biomarker superiority.
Finished product matters.
Which forms and label details matter?
Krill oil contains omega-3s in phospholipid and triglyceride fractions plus variable astaxanthin. Compare the declared EPA+DHA dose, not capsule count or oil mass. Source species, allergens and oxidation control belong on the record.
How should it be stored?
Follow the label, close the container and protect it from heat, light and moisture.
Read the label before the claim
Do not merge the units.
Then frequency and total.
Keep duration and population.
What is it commonly used for?
Krill oil is marketed as a more absorbable alternative to fish oil. Biomarker comparisons do not establish fewer cardiovascular events, superior cognition or a universal lower dose.
What does human research show?
Ulven randomized 113 adults to krill oil, fish oil or no supplement. Krill delivered 543 mg EPA+DHA/day versus 864 mg/day from fish oil for seven weeks; both raised plasma long-chain omega-3s, with no significant between-oil difference in omega-3 changes, serum lipids, oxidative-stress or inflammatory markers. [2] Deinema randomized 60 adults with mild-to-moderate dry eye to krill oil, fish oil or olive oil for 90 days. The krill arm supplied 1,455 mg EPA+DHA/day; the small single-site, condition-specific study cannot establish general superiority. [3] A 2026 pilot randomized 47 participants and compared 825 mg/day phospholipid-bound with 903 mg/day standard omega-3 in mild-to-moderate hypertriglyceridemia and did not find statistically significant differences in triglycerides or omega-3 index. [4] Krill evidence should remain attached to active EPA+DHA, formulation and endpoint, while the broader high-dose marine omega-3 atrial-fibrillation signal remains relevant. [1]

How might it act?
Fatty acids enter membranes, serve as energy substrates or act as precursors to mediators according to their structure. This mechanism does not turn a blood-level change into prevention of a clinical event.
How does it compare with related products?
| Product | What the label needs to state | Practical distinction |
|---|---|---|
| Fish oil | EPA, DHA and total oil | Marine EPA+DHA mixture; findings from an EPA-only prescription drug do not automatically transfer. |
| Krill oil | EPA, DHA, phospholipids and shellfish source | Different source with a shellfish allergen; total oil mass does not reveal EPA+DHA mass. |
| Algal oil | DHA, any EPA and total oil | Non-fish source; formulations can be mainly DHA. |
| Cod liver oil | EPA, DHA, vitamin A and vitamin D | Adds fat-soluble vitamins that must be counted with other products. |
What are the risks and interactions?
Avoid krill products with crustacean allergy unless an allergist explicitly clears the finished product. Review anticoagulants, antiplatelets, surgery and prior atrial fibrillation. GI symptoms and aftertaste occur; astaxanthin does not prove product stability or clinical superiority.
Which medicines require review?
Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.
Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]
What should be monitored?
Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.
What happens when it is stopped?
No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.
Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.
What do public communities report?
Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.
Common questions about Krill Oil
Is krill oil better absorbed than fish oil?
Some biomarker studies differ, but clinical superiority is not established and active doses often differ.
Is 1 g krill oil equal to 1 g EPA+DHA?
No. Read the declared EPA and DHA amounts.
Does astaxanthin make it safer?
No clinical safety guarantee follows from pigment content.
Can people with shellfish allergy take it?
Do not assume safety; krill is a crustacean and the finished product needs professional review.
Does it prevent heart attacks?
No large clinical-outcome evidence establishes retail krill oil for event prevention.
What should I track?
Species/source, oil mass, phospholipid amount, EPA, DHA, astaxanthin, lot, symptoms and review date.
Glossary
Terms for reading the evidence.
- ALA
- Essential 18-carbon omega-3; adult AIs refer to this form.
- EPA
- Long-chain omega-3; distinct from total oil weight.
- DHA
- Long-chain omega-3; often present in a different amount from EPA.
- Amount per administration
- Amount consumed at one time, distinct from daily total.
- Biomarqueur
- Biological measure that is not necessarily a clinical benefit.
- UL
- Tolerable Upper Intake Level established for a nutrient and defined scope.
How this guide was researched
Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.
Explore the sources
Sources preserve form, amount, frequency, population, duration and outcome.
Showing 6 sources
- 01
Omega-3 Fatty Acids - Health Professional Fact Sheet ↗
Official nutrient monograph
Current page or report reviewed; scope and limits retained.
Detail: EPA/DHA sources, ALA-only DRI, health evidence, safety and interactions.
- 02
Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. ↗
Randomized comparative trial
Current page or report reviewed; scope and limits retained.
Detail: 113 adults; exact krill and fish active doses; seven-week biomarker outcomes.
- 03
A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. ↗
Small dry-eye randomized trial
Current page or report reviewed; scope and limits retained.
Detail: 60 participants; krill, fish and olive-oil arms; 90 days.
- 04
Efficacy of phospholipid-bound omega-3 versus standard omega-3 in patients with hypertriglyceridemia: a randomized clinical trial. ↗
Randomized pilot formulation comparison
Current page or report reviewed; scope and limits retained.
Detail: 47 randomized, 44 completed; 825 versus 903 mg EPA+DHA/day for 12 weeks; no significant formulation difference in TG or omega-3 index.
- 05
Questions and Answers on Dietary Supplements ↗
U.S. regulatory overview
Current page or report reviewed; scope and limits retained.
Detail: Supplements generally lack efficacy preapproval.
- 06
Product Licensing ↗
Canadian licensing overview
Current page or report reviewed; scope and limits retained.
Detail: Finished natural health products require licensing and authorized labels.
No matching sources
Try a different term or show the full list.